Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUPROPION HYDROBROMIDE

BUPROPION HYDROBROMIDE

Standard Dose
522MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview BUPROPION HYDROBROMIDE is listed in Drugs@FDA under application 200835 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient BUPROPION HYDROBROMIDE Form and strength TABLET, EXTENDED RELEASE; ORAL - 522MG Sponsor WATSON LABS INC Submission history Latest submission status date: 2013-08-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUPROPION HYDROBROMIDE is listed in Drugs@FDA under application 200835 (ANDA). Marketing status: None (Tentative Approval) Active ingredient BUPROPION HYDROBROMIDE Form and strength TABLET, EXTENDED RELEASE; ORAL - 522MG Sponsor WATSON LABS INC Submission history Latest submission status date: 2013-08-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.